Chardan's Amusa Is Downgrading Amicus Therapeutics: Here's Why
September 16, 2015 at 11:40 AM EDT
Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares have jumped 109 percent year-to-date, and are trading close to the higher end of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.